Sitra

Sitra is a Finnish government agency based in Helsinki, established in 1967. It serves as the venture capital investment arm of the Finnish Innovation Fund, focusing on seed and early-stage investments. Sitra specializes in three primary programmes: Health Care, Food and Nutrition, and Environmental. The Health Care Programme targets companies involved in paper-free health care, seamless service delivery, and decentralized specialized health care solutions. The Food and Nutrition Programme invests in businesses that enhance the food and nutrition sector through innovative applications and the value-added processing of raw materials. Through these initiatives, Sitra aims to support projects that promote economic efficiency, improve education and research, and explore future development scenarios, thereby enhancing Finland's international competitiveness.

Mikko Kosonen

President

Sami Tuhkanen

Vice President, Investments

Past deals in Finland

Headai

Grant in 2018
Headai Ltd. specializes in the development of software robots that automate a range of intellectual tasks for businesses. Founded in 2015 and based in Pori, Finland, the company provides a cloud service featuring teachable robots that can assist with everyday operations, corporate learning, and content discovery tailored to individual interests. Utilizing advanced algorithms that incorporate natural language processing and self-organized learning, Headai's technology enables clients to uncover insights from large datasets and recognize previously hidden connections. The software robots are designed to be interactive and adaptable, allowing organizations to streamline repetitive processes and improve efficiency in their operations.

Visionplus

Venture Round in 2012
VisionPlus is a Finnish venture capital firm established in 2011, located in Helsinki. The firm focuses on investing in digital products, including applications, games, and services across various digital platforms. Its investment portfolio encompasses software-as-a-service, mobile applications, and internet services, as well as special content intellectual property deals. The management team at VisionPlus possesses extensive experience in technology, entrepreneurship, and seed investments, having successfully developed and managed large-scale business and development organizations in a global context.

Savosolar

Venture Round in 2011
Savo-Solar Oy, a Mikkeli, Finland-based manufacturer of solar thermal solutions.

Nexstim

Venture Round in 2011
Nexstim Plc is a medical technology company based in Helsinki, Finland, specializing in non-invasive brain stimulation technologies. Founded in 2000, it focuses on developing and marketing navigated transcranial magnetic stimulation (nTMS) systems, utilizing its proprietary SmartFocus technology with 3D navigation for precise targeting of brain regions. The company offers the NBT system for treating major depressive disorder and chronic neuropathic pain, as well as the NBS system for pre-surgical mapping of speech and motor cortices. Nexstim primarily serves universities and teaching hospitals, with a significant portion of its revenue generated in North America and its products marketed across Europe and internationally.

Nexstim

Venture Round in 2007
Nexstim Plc is a medical technology company based in Helsinki, Finland, specializing in non-invasive brain stimulation technologies. Founded in 2000, it focuses on developing and marketing navigated transcranial magnetic stimulation (nTMS) systems, utilizing its proprietary SmartFocus technology with 3D navigation for precise targeting of brain regions. The company offers the NBT system for treating major depressive disorder and chronic neuropathic pain, as well as the NBS system for pre-surgical mapping of speech and motor cortices. Nexstim primarily serves universities and teaching hospitals, with a significant portion of its revenue generated in North America and its products marketed across Europe and internationally.

Vivoxid

Venture Round in 2005
Vivoxid Ltd. develops, manufactures, and markets biomaterial products for the medical device sector. The company offers MetAlive soft tissue attachment technology for implant surfaces. BonAlive bioactive glass and biodegradable polymer composite products in bone reconstruction and FiberLive biodegradable fiberglass composites for load-bearing biodegradable implants. It has distributors in northern Europe, the United Kingdom, southern Europe, Italy, Greece, Turkey, the Middle East, and Saudi Arabia. The company was founded in 2001 and is based in Turku, Finland.

Ipsat Therapies

Series C in 2005
Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.